Recombinant Human PSMA protein (His tag N-Terminus + Avi tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human PSMA protein (His tag N-Terminus + Avi tag N-Terminus) is a Human Fragment protein, in the 44 to 750 aa range, expressed in HEK 293 cells, with >90%, suitable for SDS-PAGE.
View Alternative Names
FOLH, NAALAD1, PSM, PSMA, GIG27, FOLH1, Glutamate carboxypeptidase 2, Cell growth-inhibiting gene 27 protein, Folate hydrolase 1, Folylpoly-gamma-glutamate carboxypeptidase, Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, N-acetylated-alpha-linked acidic dipeptidase I, Prostate-specific membrane antigen, Pteroylpoly-gamma-glutamate carboxypeptidase, FGCP, GCPII, mGCP, NAALADase I
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human PSMA protein (His tag N-Terminus + Avi tag N-Terminus) (AB271724)
SDS-PAGE analysis of 4 μg ab271724.
This protein runs at a higher molecular weight due to glycosylation.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Specifications
Form
Liquid
General info
Function
Has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Has a preference for tri-alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Involved in prostate tumor progression.. Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.
Sequence similarities
Belongs to the peptidase M28 family. M28B subfamily.
Post-translational modifications
The first two amino acids at the N-terminus of isoform PSMA' appear to be cleaved by limited proteolysis.. The N-terminus is blocked.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com